Pilot Therapeutics Asthma Supplement Eyes First Quarter 2001 Launch
This article was originally published in The Tan Sheet
Executive Summary
Pilot Therapeutics' first dietary supplement - specifically designed for asthmatics - will not bear the disease name on labeling. Instead, the product will be marketed as inhibiting the production of leukotrienes, which are asthma biomarkers, Pilot said.